315 related articles for article (PubMed ID: 8445208)
1. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
[TBL] [Abstract][Full Text] [Related]
2. Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosis.
Braillon A; Cailmail S; Gaudin C; Lebrec D
J Hepatol; 1993 Jan; 17(1):86-90. PubMed ID: 8445224
[TBL] [Abstract][Full Text] [Related]
3. Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
Reboredo M; Chang HC; Barbero R; Rodríguez-Ortigosa CM; Pérez-Vizcaíno F; Morán A; García M; Banales JM; Carreño N; Alegre F; Herrero I; Quiroga J; Prieto J; Sangro B
PLoS One; 2013; 8(1):e52683. PubMed ID: 23341903
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive rats.
Huang YT; Tsai JF; Lin HC; Chen CF; Hong CY
Can J Physiol Pharmacol; 1997; 75(10-11):1220-5. PubMed ID: 9431446
[TBL] [Abstract][Full Text] [Related]
5. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
Pizcueta MP; de Lacy AM; Kravetz D; Bosch J; Rodés J
Hepatology; 1989 Dec; 10(6):953-7. PubMed ID: 2583690
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic effects of octreotide in portal hypertensive rats receiving propranolol.
Moreau R; Cailmail S; Gadano A; Valla D; Lebrec D
Aliment Pharmacol Ther; 1997 Aug; 11(4):775-9. PubMed ID: 9305488
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective beta-blocker.
Vachiery F; Moreau R; Gadano A; Yang S; Sogni P; Hadengue A; Cailmail S; Soupison T; Lebrec D
Dig Dis Sci; 1996 Sep; 41(9):1722-6. PubMed ID: 8794785
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of nipradilol, a new beta-adrenergic antagonist combined with a nitroxy base, in rats with intra- or extra-hepatic portal hypertension.
Ohsuga M; Cailmail S; Lebrec D
J Hepatol; 1993 Feb; 17(2):236-40. PubMed ID: 8095275
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
Moreau R; Cailmail S; Valla D; Lebrec D
Aliment Pharmacol Ther; 1997 Oct; 11(5):993-7. PubMed ID: 9354212
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats.
Oberti F; Veal N; Kaassis M; Pilette C; Rifflet H; Trouvé R; Calès P
J Hepatol; 1998 Jul; 29(1):103-11. PubMed ID: 9696498
[TBL] [Abstract][Full Text] [Related]
11. Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats.
Koshy A; Girod C; Lee SS; Hadengue A; Cerini R; Lebrec D
Hepatology; 1989 Feb; 9(2):269-73. PubMed ID: 2912829
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats.
Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D
J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735
[TBL] [Abstract][Full Text] [Related]
13. Systemic and splanchnic hemodynamics following hemorrhage and volume restitution with Haemaccel in portal hypertensive rats: the effect of propranolol.
Hilzenrat N; Arish A; Yaari A; Sikuler E
J Gastroenterol Hepatol; 2001 Jul; 16(7):796-800. PubMed ID: 11446889
[TBL] [Abstract][Full Text] [Related]
14. Terlipressin is more effective in decreasing variceal pressure than portal pressure in cirrhotic patients.
Romero G; Kravetz D; Argonz J; Bildozola M; Suarez A; Terg R
J Hepatol; 2000 Mar; 32(3):419-25. PubMed ID: 10735611
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats.
Huang YT; Cheng YR; Lin HC; Hou MC; Lee SD; Hong CY
Dig Dis Sci; 1998 Feb; 43(2):358-64. PubMed ID: 9512131
[TBL] [Abstract][Full Text] [Related]
17. Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism.
Asfar P; Hauser B; Iványi Z; Ehrmann U; Kick J; Albicini M; Vogt J; Wachter U; Brückner UB; Radermacher P; Bracht H
Crit Care Med; 2005 Feb; 33(2):373-80. PubMed ID: 15699842
[TBL] [Abstract][Full Text] [Related]
18. Effects of alpha 1 and beta-adrenergic antagonists and 5-hydroxytryptamine receptor antagonist on portal-systemic collateral vascular resistance in conscious rats with portal hypertension.
Koshy A; Sekiyama T; Hadengue A; Cerini R; Braillon A; Lebrec D
J Gastroenterol Hepatol; 1992; 7(5):449-54. PubMed ID: 1391726
[TBL] [Abstract][Full Text] [Related]
19. Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats.
Calès P; Braillon A; Girod C; Lebrec D
J Hepatol; 1985; 1(4):349-57. PubMed ID: 4056347
[TBL] [Abstract][Full Text] [Related]
20. Effects of reserpine administration in two models of portal hypertension in rats.
Lin HC; Yu PC; Lee SD; Tsai YT; Kuo JS; Yang MC
J Hepatol; 1993 Nov; 19(3):413-7. PubMed ID: 8151103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]